Cyprium Partners is a private equity and mezzanine firm providing non-control capital to middle-market companies in North America. With over 25 years of experience, the firm tailors debt and minority equity investments to support corporate objectives, focusing on manufacturing, distribution, business services, healthcare, and technology-enabled sectors. Cyprium Partners has invested $1.9 billion across 100 platform investments, maintaining offices in Cleveland, New York, and Chicago.
Leadership
| Name | Title | ||
|---|---|---|---|
| Dan Kessler | Partner |
in/daniel-kessler-14842673
|
|
| Partner |
|
||
| Partner |
|
||
| Partner |
|
||
| Partner |
|
||
| Partner |
|
||
| Partner |
|
||
| Partner |
|
||
| Principal |
|
||
| Managing Director |
|
||
| Vice President |
|
||
| Vice President |
|
Recent Transactions involving Cyprium Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Cyprium Completes Investment in OneroRx, Marking the Group's 100th Platform Investment |
OneroRx |
Cyprium Partners |
Pharmacy Services | |
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →